HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.
Pharmacologic Treatments for COVID-19

During corona virus, the FDA has issued an emergency use authorization (EUA) for bamlanivimab, which is a monoclonal antibody given against the spike protein of SARS-CoV-2

Baricitinib or JAK inhibitor is used in combination with remdesivir, in the treatment of suspected or laboratory-confirmed coronavirus disease in hospitalized patients aged 2 years and elderly who require supplemental oxygen, invasive mechanical ventilation. Various other antiviral agents, immunotherapies, and vaccines continue to be investigated and developed as possible therapies.

Committee Members
Speaker at Drug Delivery Events - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Pharmaceutical Conference - Consolato M Sergi

Consolato M Sergi

Universities of Alberta and Ottawa, Canada
Speaker at Drug Delivery Events - Vladlen Slepak

Vladlen Slepak

University of Miami Miller School of Medicine, United States
Speaker at Drug Delivery Events -  Andreas M Papas

Andreas M Papas

Antares Health Products, United States
PDDS 2025 Speakers
Speaker at Pharmaceutical Conference - Axel H Schonthal

Axel H Schonthal

University of Southern California, United States
Speaker at Pharmaceutical Conference - Bernd Blobel

Bernd Blobel

University of Regensburg, Germany
Speaker at Pharma Conferences - Gurpreet Singh

Gurpreet Singh

IQVIA, United Kingdom
Speaker at Pharma Conferences - Rassa Pegahi

Rassa Pegahi

UPSA, France
Speaker at Drug Delivery Events - Tanuja Tummala

Tanuja Tummala

Harrisburg University of Science and Technology, United States
Speaker at Drug Delivery Events - Natassa Pippa

Natassa Pippa

University of Athens, Greece

Submit your abstract Today

Watsapp